F

Faes Farma SA
MAD:FAE

Watchlist Manager
Faes Farma SA
MAD:FAE
Watchlist
Price: 3.46 EUR 0.44% Market Closed
Market Cap: 1.1B EUR
Have any thoughts about
Faes Farma SA?
Write Note

Faes Farma SA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Faes Farma SA
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
F
Faes Farma SA
MAD:FAE
Cash from Financing Activities
-€24.2m
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Almirall SA
MAD:ALM
Cash from Financing Activities
-€32.7m
CAGR 3-Years
N/A
CAGR 5-Years
12%
CAGR 10-Years
N/A
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Cash from Financing Activities
-€104.8m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratorio Reig Jofre SA
MAD:RJF
Cash from Financing Activities
€7.2m
CAGR 3-Years
-20%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

Faes Farma SA
Glance View

Market Cap
1.1B EUR
Industry
Pharmaceuticals

Faes Farma SA operates as a pharmaceutical company. The company is headquartered in Madrid, Madrid and currently employs 1,661 full-time employees. The firm specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The firm operates in Spain, Portugal, Chile and Mexico, among others. The company controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

FAE Intrinsic Value
2.88 EUR
Overvaluation 17%
Intrinsic Value
Price
F

See Also

What is Faes Farma SA's Cash from Financing Activities?
Cash from Financing Activities
-24.2m EUR

Based on the financial report for Jun 30, 2024, Faes Farma SA's Cash from Financing Activities amounts to -24.2m EUR.

What is Faes Farma SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
16%

Over the last year, the Cash from Financing Activities growth was 3%.

Back to Top